One in four people experience mild side effects from Covishield vaccine: Lancet study
The Hindu
Systemic effects included headache, fatigue, chills and shiver, diarrhoea, fever, arthralgia, myalgia, and nausea.
One in four people experience mild, short lived systemic side effects after receiving the COVID-19 preventive by Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccine — known as Covishield in India — with headache, fatigue and tenderness the most common symptoms, published in the Lancet Infectious Diseases journal. The researchers from King's College London in the U.K. also found that most systemic side effects — meaning side effects excluding where the injection took place — peaked within the first 24 hours following vaccination and usually lasted 1-2 days. Systemic effects included headache, fatigue, chills and shiver, diarrhoea, fever, arthralgia, myalgia, and nausea. Local side effects — meaning side effects where the injection took place in the arm — included pain at the site of injection, swelling, tenderness, redness, itch, warmth and swollen armpit glands.More Related News
Podcasts have become our best friends, especially during the Covid-19 pandemic. Whether you are cooking, sketching or going on an evening walk, there is a show that matches your mood. From horror tales to informative conversations to just two friends talking about anything & everything relatable, podcasts have become a part of our lives unknowingly. Over the years, more voices have joined this audio landscape and filled it with stories that resonate with our lives. Podcasts serve as a reminder that everyone has a story worth telling and listening to!